Pathogen-Reduced Platelets for the Prevention of Bleeding in People of Any Age.
JAMA Oncol
; 4(4): 571-572, 2018 Apr 01.
Article
en En
| MEDLINE
| ID: mdl-29372241
ABSTRACT
CLINICAL QUESTION Are pathogen-reduced platelets as effective as standard platelets for the prevention of bleeding in people of any age requiring platelet transfusions? BOTTOM LINE In people with cancer who have a low platelet count due to their disease or its treatment, pathogen-reduced platelet transfusions increase risk of platelet refractoriness and platelet transfusion requirement (high-quality evidence) but probably do not effect all-cause mortality, risk of clinically significant or severe bleeding, or risk of a serious adverse event (moderate-quality evidence). There was insufficient evidence for people with other diagnoses.
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Trombocitopenia
/
Transfusión de Plaquetas
/
Transmisión de Enfermedad Infecciosa
/
Hemorragia
/
Neoplasias
Tipo de estudio:
Systematic_reviews
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Child, preschool
/
Humans
/
Middle aged
Idioma:
En
Revista:
JAMA Oncol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Reino Unido